SCHEMBL3791972

SCHEMBL3791972

Nc1c(Cl)cccc1Sc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 3/20 0.44
SIRT1 Q96EB6 1/20 0.43
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.42
NSD2 O96028 1/20 0.42
MAPK1 P28482 1/20 0.42
HPGD P15428 3/20 0.41
PDE7A Q13946 3/20 0.40
ADORA2A P29274 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PRMT1 Q99873 1/20 0.39
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.38
TYMS P04818 2/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA3 P07451 1/20 0.38
CA4 P22748 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3784489 0.81 PDE7A (0.50) SIRT1KDM4EMAPTNSD2MAPK1
Methylphenylsulfide SCHEMBL8306381 0.79 CYP1A1 (0.40) DHFRKDM4EMAPTMAPK1HPGD
SCHEMBL433052 0.79 DHFR (0.46) DHFRSIRT1KDM4EMAPTNSD2
SCHEMBL1158036 0.79 CYP1A2 (0.45) DHFRSIRT1KDM4EMAPTNSD2
SCHEMBL3785191 0.78 MAPT (0.43) DHFRSIRT1KDM4EMAPTNSD2
SCHEMBL11262387 0.76 MEN1 (0.44) DHFRKDM4EMAPTHPGDALDH1A1
SCHEMBL3791257 0.76 MAPT (0.48) DHFRSIRT1KDM4EMAPTNSD2
SCHEMBL3793221 0.74 MAPT (0.49) DHFRSIRT1KDM4EMAPTNSD2
SCHEMBL3790383 0.73 ALDH1A1 (0.48) DHFRSIRT1KDM4EMAPTNSD2
SCHEMBL3786990 0.72 MAPT (0.42) DHFRKDM4EMAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 DHFR 763/4885SIRT1 2959/4885KDM4E 2606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.